


Ask a doctor about a prescription for ZONISAMIDE KERN PHARMA 50 mg HARD CAPSULES
Package Leaflet: Information for the User
Zonisamide Kern Pharma 50 mg hard capsules EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
This medicine contains the active substance zonisamide and is used as an antiepileptic.
Zonisamide is used to treat seizures that affect only a part of the brain (partial seizures), which may or may not be followed by a seizure that affects the entire brain (secondary generalization).
Zonisamide may be used:
Do not take Zonisamide Kern Pharma:
Warnings and precautions
Zonisamide belongs to a group of medicines (sulfonamides) that can cause severe allergic reactions, severe skin reactions, and blood disorders, which can very rarely be life-threatening (see section 4).
There have been reports of severe skin reactions associated with zonisamide therapy, including cases of Stevens-Johnson syndrome. |
The use of Zonisamide may cause high levels of ammonia in the blood, which could change brain function, especially if you are also taking other medicines that can increase ammonia levels (e.g., valproate), if you have a genetic disorder that causes too much ammonia to be produced in the body (urea cycle disorder), or if you have liver disease. Tell your doctor immediately if you feel unusually drowsy or confused.
Talk to your doctor or pharmacist before you start taking this medicine:
If any of these statements apply to you, tell your doctor before taking this medicine.
Children and adolescents
Talk to your doctor about the following risks:
Prevention of excessive heat and dehydration in children This medicine can cause children to sweat less or have excessive heat; this can cause brain damage and death if not treated. Children are the most vulnerable population, especially on hot days. When the child is taking this medicine:
carbonic anhydrase inhibitors (e.g., topiramate and acetazolamide) and anticholinergics (e.g., clomipramine, hydroxyzine, diphenhydramine, haloperidol, imipramine, and oxybutynin). If your child's skin is very hot with little or no sweating, the child feels confused or has muscle cramps, or their heart rate or breathing is rapid.
|
Do not give this medicine to children under 6 years old, as it is not known if the potential benefits are greater than the risks in this age group.
Using Zonisamide Kern Pharma with other medicines
Tell your doctor or pharmacist if you are using or have recently used any other medicines, including those obtained without a prescription.
Taking Zonisamide Kern Pharma with food and drinks
Zonisamide can be taken with or without food.
Pregnancy, breastfeeding, and fertility
Women of childbearing age must use effective contraceptive measures during treatment with zonisamide and for one month after stopping this medicine.
If you plan to become pregnant, talk to your doctor before stopping contraception and before becoming pregnant about the possibility of switching to other suitable treatments. If you are or think you may be pregnant, tell your doctor immediately. Do not stop treatment without consulting your doctor.
You should only take zonisamide during pregnancy if your doctor advises you to. Research shows a higher risk of birth defects in children of women who take antiepileptics. It is not known what the risk of birth defects or developmental neurological disorders (brain development problems) is for your child after taking zonisamide during pregnancy. A study showed that children whose mothers used zonisamide during pregnancy were smaller than expected for their age at birth, compared to children whose mothers were treated with lamotrigine monotherapy. Make sure you are fully informed about the risks and benefits of using zonisamide for epilepsy during pregnancy.
Do not breastfeed while taking zonisamide or for one month after stopping this medicine.
There is no clinical data on the effects of zonisamide on human fertility. Animal studies have shown changes in fertility parameters.
Driving and using machines
Zonisamide can affect concentration, reaction ability, and may make you feel drowsy, especially at the start of treatment or after increasing the dose. If zonisamide affects you in this way, be especially careful when driving or using machines.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.
The usual dose in adults:
If you take Zonisamida Kern Pharma alone:
If you take Zonisamida Kern Pharma with other antiepileptics:
Use in children (6 to 11 years) and adolescents (12 to 17 years) who weigh at least 20 kg:
Example: a child who weighs 25 kg should take 25 mg once a day during the first week, and then the daily dose should be increased by 25 mg at the start of each week until the daily dose of 150 to 200 mg is reached.
If you think the effect of zonisamide is too strong or too weak, tell your doctor or pharmacist.
If you take more Zonisamida Kern Pharma than you should
If you have taken more zonisamide than you should, tell the person taking care of you (family or friend), your doctor, or pharmacist, or contact the emergency department of the nearest hospital and take the medicine with you. You may feel drowsy and may lose consciousness. You may also feel like vomiting, have stomach pain, muscle spasms, eye movement, feel like you are going to faint, have a slow heart rate, and decreased kidney function. Do not try to drive.
If you forget to take Zonisamida Kern Pharma
If you forget to take a dose, do not worry; take the next dose at the usual time.
Do not take a double dose to make up for forgotten doses.
If you stop taking Zonisamida Kern Pharma
Zonisamide is intended to be taken as a long-term medicine. Do not reduce the dose or stop taking the medicine unless your doctor tells you to.
If your doctor advises you to stop treatment, they will gradually reduce the dose to minimize the risk of having more seizures.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Zonisamide belongs to a group of medicines (sulfonamides) that can cause severe allergic reactions, severe skin reactions, and blood disorders, which can very rarely be life-threatening.
Contact your doctor immediately if:
Contact your doctor as soon as possible if:
Your doctor may decide that you should stop taking zonisamide.
The most common side effects of zonisamide are all mild. They occur during the first month of treatment and often decrease as treatment continues. In children from 6 to 17 years old, the side effects were consistent with those described below, except for the following exceptions: pneumonia, dehydration, decreased sweating (frequent), and abnormal liver enzymes (uncommon).
Very common side effects: may affect more than 1 in 10 people
Common side effects: may affect up to 1 in 10 people
Uncommon side effects: may affect up to 1 in 100 people
Rare side effects: may affect up to 1 in 10,000 people
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medication out of sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not use this medication if you notice any signs of deterioration in the capsules, blisters, or box, or any visible signs of deterioration in the medication. Return the packaging to your pharmacist.
Medications should not be thrown away in drains or trash. Deposit the packaging and medications you no longer need at the SIGRE Point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Zonisamida Kern Pharma
The capsule shell contains: titanium dioxide and gelatin.
The printing ink contains: Shellac and red iron oxide (E-172).
Appearance of the Product and Package Contents
Hard white capsules marked with "Z 50".
Package sizes:
Blisters of 28 and 56 capsules.
Only some package sizes may be marketed.
Marketing Authorization Holder
Kern Pharma S.L
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa - Barcelona
Spain
Manufacturer
NOUCOR HEALTH, S.A.
Av. Camí Reial, 51-57
08184 – Palau-solità i Plegamans
Barcelona
Spain
Date of the Last Revision of this Leaflet:March 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of ZONISAMIDE KERN PHARMA 50 mg HARD CAPSULES in October, 2025 is around 19.39 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ZONISAMIDE KERN PHARMA 50 mg HARD CAPSULES – subject to medical assessment and local rules.